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1. Introduction
  Schistosomiasis remains one of the most prevalent 
parasitic infections in the world. It has been estimated 
that more than 207 million people are infected and 779 
million people are at risk of infection[1]. Schistosomiasis, 
also known as bilharzia, is a parasitic disease that leads 
to chronic ill health. It is the major health risk in the 
rural areas of China and South East Asia and continues to 
rank high in other developing countries[2]. The disease is 
diagnosed either by the presence of blood in the urine or, in 
the case of intestinal schistosomiasis, by initially atypical 
symptoms which can lead to serious complications involving 
the liver[2]. Schistosomiasis, caused by various Schistosoma 
species, is estimated to cause infection in more than 200 
million people in rural agricultural and peri-urban areas in 
tropical and subtropical developing countries particularly 
in China, Africa and South America[3,4]. In South East Asia, 
Schistosoma japonicum is prevalent in southern Philippines 
and Indonesia, whereas Schistosoma mekongi is endemic in 
the Mekong Delta[5,6]. In Malaysia, Schistosoma malayensis 
(S. malayensis) were detected among the Orang Asli in west 
Malaysia, while an evidence of Schistosoma was found in 
a monkey and in liver and rectal biopsies of immigrants 
from Philippines[7-10]. In Sarawak, environmental impact 
assessment (EIA) survey in upper Lupar River and upper 
Rejang River found eight individuals who were active 
schistosome eggs excretes. A sero-survey found 16.2% were 
seropositive for schistosomiasis, however the snail host 
could be identified and the S. malayensis-like infection 
among the Penan and other interior tribes (Orang Ulu) in 
upper Rejang River Basin was reported[11,12]. 
  The research for a new and natural source to be used as 
a protection for schistosomiasis was increased in the last 
decade. The medicinal plants provide a new, available and 
Objective: To evaluate a protective effect of Aristolochia gehrtii (A. gehrtii) leaves to inhibit 
liver toxicity and apoptosis in Schistosoma malayensis (S. malayensis) infection. Methods: 
Forty male albino mice were divided into four equal groups: group 1 control including non-
infected healthy mice and groups 2, 3 & 4 subcutaneously infected with S. malayensis cercariae 
where groups 3 & 4 pretreated with A. gehrtii leaves (200 mg/kg, bwt) & cinnamoylamide (250 
mg/kg, bwt), respectively. Results: S. malayensis caused a significant increase in serum AST, 
ALT, ALP, MDA, NO, bilirubin, urea, creatinine, total cholesterol, LDL, triglycerides, and HDL 
levels. The pretreatment of A. gehrtii leaves and cinnamoylamide significantly inhibited that 
increase. On the other hand, S. malayensis induced a significant decrease in serum total protein, 
albumin, globulin, albumin/globulin ratio, blood SOD and GPx, while A. gehrtii leaves and 
cinnamoylamide pretreatment increased the above parameters. Treatment with A. gehrtii leaves 
and cinnamoylamide to S. malayensis infected mice increased p53 expression but decreased bcl-2 
expression. These results were supported by histopathological investigations. Conclusions: A. gehrtii
inhibits liver toxicity and apoptosis in S. malayensis infection and this effect is associated with 
the major cinnamoylamide ingredient of A. gehrtii leaves.
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cheap source for developing new drugs nowadays. Natural 
products account for more than 40% of all pharmaceuticals 
on the market today, where from 1941 to 2002, over 50% 
of all the drugs, or new drug entities, available for cancer 
treatment were derived from natural resources[13].
  Aristolochiaceae family is widely distributed in tropical, 
subtropical and temperate regions of the world. They are 
known to occur in Asia, Africa, North and South America and 
Australia. It is represented by three genera: Aristolochia, 
which consists of approximately 100 species, Holostylis 
and Euglypha, each of which consists of only one species 
Holostylis reniformis and Euglypha rojasiana[14]. The latter 
have been suggested to be included in the Aristolochia 
genus[15]. With regard to synonyms, more than 300 names 
have been proposed for these species. The majority of the 
Aristolochiales are tropical, though a number of them range 
as far north as Canada, Scandinavia, and Northern Japan. 
Aristolochia species are herbaceous perennials, under-
shrubs or shrubs, often scandent, scrambling, twining, 
sometimes lianas, usually with prostrate or tuberous 
rhizomes or rootstocks, and alternate, pinnate, polymorphic 
or lobed leaves[16-18]. In traditional medicine, these 
plants are known as “one thousand men” and have been 
mainly used as abortifacients, stomachics, antiophidians, 
antiasthmatics, expectorants, and, recently, in slimming 
therapies[14].
  The selection of Aristolochia gehrtii (A. gehrtii) leaves for 
the current study was due to its major bioactive alkamides 
constituents[19], where amides have antioxidant activity[20]. 
The purpose of the present study was to discover a new 
natural adjunctive therapeutic agent to treat S. malayensis-
like infection complications in liver tissue. To accomplish 
this, we measured several oxidative stress and apoptosis 
parameters to determine if S. malayensis induces oxidative 
stress in liver and if this stress could be prevented by the 
use of A. gehrtii leaves extract.
2. Materials and methods
2.1. Plant material and ethanolic extract
  A. gehrtii leaves were provided from Penang Botanical 
Garden, Penang, Malaysia in September 2012. The plant 
was botanically identified authenticated at School of 
Pharmaceutical Science, Universiti Sains Malaysia, Malaysia. 
Voucher specimen of each plant was deposited at the 
herbarium of the pharmacy school. The leaves were crushed, 
pulverized and then weighed and prepared for extraction.
  A. gehrtii leaves (5 kg) were air-dried in an oven at
40 曟 for 4 d and then the dry leaves was cut and pulverized. 
Then, they were subjected to size reduction to get coarse 
powder. The powdered material was subjected to successive 
extraction in a Soxhlet apparatus using solvent petroleum 
ether (40-60 曟) and ethyl alcohol. This powder was vacuum 
dried in a desiccator’s till it was free from moisture[21]. 
2.2. Mice 
  Forty male albino mice (20-25 g) were obtained from the 
animal house of the Advanced Medical and Dental Institute, 
Universiti Sains Malaysia, Malaysia and were kept in 
special plastic cages. The animals were maintained on a 
commercial balanced diet and tap water. The experiments 
were performed after approval from the ethics committee 
of the Universiti Sains Malaysia and in accordance with 
recommendations for the proper care and use of laboratory 
animals (NIH publication no. 85:23 revised 1985).
2.3. Estimation of lethal dose 50 (LD50) of the extract
  Twenty-four mice were orally administered the leaves 
extract with different four concentrations (1, 3, 5 and 7 
mg/kg, bwt). Six rats were kept as control group throughout 
the entire experimental period. Mortality was assessed 
and counted in the different groups. LD50 was calculated 
according to the method of Behrens and Karber[22]. Finally, 
1/10 of the LD50 was found to be safe[23].
2.4. Thin layer chromatography (TLC) for isolation of leaves 
extract alkamide
  TLC was used to resolve and isolate the cinnamoylamide 
constituent from leaves extract. Precoated silica gel plates 
(20×20 cm, Brinkman Silplate F-22, with fluorescent 
indicator, 0.25, 0.50, or 2.00 mm gel thickness) were used 
in all separations. With these plates, the substituted amide 
present was easily detected as yellow or golden bands by 
viewing the developed plates under long-wave ultraviolet 
light. Amide was isolated by applying the extract as bands 
to TLC plates, developing in appropriate solvent systems, 
locating the compounds under ultraviolet light, and then 
scraping and eluting with chloroform or acetone. Compound 
was crystallized directly from appropriate solvents (usually 
ether or ether-hexane), or if necessary, the compound was 
subjected to further cleanup by TLC. The solvent systems 
used and the numbers used to designate them are as follows: 
1, methylene chloride; 2, chloroform-ethyl acetate (2:1, v/v); 
3, methylene chloride-ether (2:1, v/v); 4, benzene-ether 
(20:1, v/v); 5, hexane-ethyl acetate-methanol (5:5:1, v/v); 
and 6, methylene chloride-ether (1:1, v/v)[19]. This process 
was taken 2 months from ethanolic extract until isolation 
of cinnamoylamide powder was obtained. The isolation 
ratio=1:5 where 60 g of cinnamoylamide ingredient obtained 
from 300 g of the extract. The dose of cinnamoylamide used 
in this study was chosen[19].
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2.5. Test for purity, quality and stability of the extract and 
cinnamoylamide
  Purity tests (microbiological, pesticide residues, heavy 
metals, radioactive residues, chemical, foreign organic 
matter and sulfated ash) were performed in accordance with 
Malaysian accepted protocol requirements and accredited 
to ISO/IEC 17025 consulting WHO guidelines on stability 
and quality controls methods for medicinal plants[24,25]. The 
leaves extract and amide were stored in a tightly cooling
(-40 曟) sealed container away from heat and light that 
prevented a loss of extract solvent and entry of water; plant 
extract or amide was dissolved in 1 mL distilled water and 
given orally to individual rat.
2.6. Experimental design 
  The mice model had been established and divided into 
four equal (10 mice each) groups as follows: (栺) Control 
group including non-infected healthy, parasite free mice 
as a control group; (栻) S. malayensis infected group 
represented by subcutaneously infected with 50 cercariae of 
S. malayensis; (栿) A. gehrtii leaves treated group comprising 
S. malayensis infected group pretreated daily with oral dose 
of A. gehrtii leaves extract (200 mg/kg, bwt) for 7 d before 
Schistosoma infection; (桇) Cinnamoylamide treated group 
including S. malayensis infected group pretreated daily with 
oral dose of cinnamoylamide (250 mg/kg, bwt) for 7 d before 
Schistosoma infection.
  All mice were anesthetized 24 h after the last oral 
administration by inhalation with diethyl ether solution. All 
mice were massed at the beginning and the end of the study.
2.7. Blood sampling and handling
  Blood samples were collected from retro-orbital plexus of 
mice using capillary tubes[26] into clean centrifuge tubes. 
Part of blood sample was collected in the presence of using 
EDTA as an anticoagulant for blood, while the other part of 
the blood sample was allowed to coagulate and centrifuged 
at 4 000 r/min for 15 min to separate blood serum which 
stored at -20 曟. 
2.8. Biochemical analysis
  To  eva lua te  l i ve r  f unc t i on ,  s e rum aspa r t a t e 
aminotransferase (AST), alanine aminotransferase (ALT), 
total bilirubin, alkaline phosphatase (ALP), total protein, 
albumin, globulin and albumin/globulin ratio were 
determined colorimetically using kits reagents obtained 
from Biomeriéux Company, France. To detect lipid fractions, 
serum total cholesterol, low-density lipoproteins (LDL), 
triglycerides and high-density lipoprotein (HDL) were 
determined colorimetically using kits reagents also obtained 
from Biomeriéux Company, France. Antioxidants enzymes 
including blood superoxide dismutase (SOD), glutathione 
peroxidase (GPx), serum lipid peroxidation (MDA) and plasma 
nitrate and nitrite concentrations as an indicator of nitric 
oxide (NO) generation were determined colorimetically using 
kits reagents purchased from Randox Company, British.
2.9. Immunohistochemical detection of p53 and bcl-2 
expression in liver tissue
  Immunohistochemical staining procedure for p53 and 
bcl-2 was performed using the methods described by Hsu 
and Raine[27] and Elias et al[28]. 
2.10. Histopathological examinations
  Specimens of liver were fixed in 10% (v/v) neutral formalin 
solution and then processed for routine technique for 
embedding in paraffin. Blocks were sectioned at a thickness 
of 5 毺m and stained with hematoxylin and eosin for 
histopathological examination, which were performed 
under light microscopy and documented by an Olympus 
microphotocamera.
2.11. Statistical analysis
  The results are expressed as mean 依 standard error (SE). 
Statistical significance was determined through one-
way analysis of variance (ANOVA), followed by Student’s t 
test. P values less than 0.05 were considered statistically 
significant. 
3. Results
3.1. Phytochemical composition and LC50 of the extract
  Phytochemical studies of the plant leaves extract showed 
the presence of six alkamides in ethanolic extract of the 
plant leaves as a major ingredient. The concentration of each 
compound were 90.2, 47.4, 50.0, 121.2, 154.8 and 119.8 mg/g
extract for alkamides compounds 1, 2, 3, 4, 5 and 6, 
respectively; so compound 5 (cinnamoylamide) was chosen 
for such study. Other chemical ingredients of the plant 
leaves extract included five lignans, three terpenes, two 
benzoic acid derivatives, and six phenethyl derivatives. 
  The maximum non-lethal dose was found to be 2 000 mg/kg;
hence 1/10 of the dose was taken as effective dose (200 
mg/kg, bwt). In the present study, there were no observable 
differences of body weight, food or drink intake during 
experimental period of the study.
3.2. Liver function
  The results presented in Table 1 indicated that S. malayensis
caused a significant increase (P<0.05) in serum AST, ALT, 
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ALP and bilirubin levels in mice. The prereatment with 
either A. gehrtii leaves extract or cinnamoylamide for 7 d 
before S. malayensis infection inhibited the increase in AST, 
ALT, ALP and bilirubin as compared to the S. malayensis-
infected mice. 
  Table 1 revealed the protective role of A. gehrtii leaves 
extract or cinnamoylamide on serum total protein, albumin, 
globulin levels, and albumin/globulin ratio in S. malayensis-
infected mice. It is obvious that S. malayensis caused 
a significant decrease (P<0.05) in serum total protein, 
albumin, globulin levels, and albumin/globulin ratio as 
compared with control healthy mice. While either A. gehrtii 
leaves extract or cinnamoylamide pretreated for 7 d before
S. malayensis infection induced a significant increase 
in total protein albumin, albumin, globulin levels, and 
albumin/globulin ratio in S. malayensis-infected mice as 
compared with S. malayensis-infected mice. On the other
hand, A. gehrtii leaves extract or cinnamoylamide 
pretreatment to S. malayensis-infected mice revealed an 
insignificant increase in serum albumin and albumin/
globulin ratio while significant increase in serum total 
protein (P<0.05) compared to S. malayensis-infected mice 
group. S. malayensis-infected mice + A. gehrtii leaves 
extract or cinnamoylamide exhibited a highly significant 
increase (P<0.01) in serum globulin.
3.3. Lipid fractions
  The data presented in Table 2 showed that S. malayensis 
induced a significant increase (P<0.05) in serum cholesterol 
on the contrary; A. gehrtii leaves extract or cinnamoylamide 
treatment to S. malayensis-infected mice exhibited an 
insignificant increase in serum cholesterol compared to 
healthy mice.
  The level of serum LDL in normal mice after being infected 
with S. malayensis and then treated with A. gehrtii leaves 
extract or cinnamoylamide was exhibited in Table 2. 
Analysis of the changes occurred in LDL after S. malayensis-
infection showed a significant increase (P<0.05) in serum 
LDL, but administration with A. gehrtii leaves extract 
or cinnamoylamide to mice infected with S. malayensis 
revealed an insignificant increase in LDL compared to 
healthy mice.
  Analysis of serum triglycerides in normal, S. malayensis 
infected- or  pretreated with either A. gehrtii leaves extract 
or cinnamoylamide to S. malayensis infected mice was 
shown in Table 2. Serum triglycerides after S. malayensis 
infection revealed a significant increase (P<0.05) in 
serum triglycerides, while A. gehrtii leaves extract or 
cinnamoylamide pretreatment to S. malayensis infected mice 
revealed an insignificant increase in serum triglycerides 
compared to healthy normal mice.
3.4. Antioxidants enzymes
  It was found that a significant decrease (P<0.05) in 
blood SOD and GPx were recorded in association with S. 
malayensis infection and the data were tabulated in Table 
3. On the contrary, the pretreatment with A. gehrtii leaves 
extract or cinnamoylamide to S. malayensis infected mice 
induced insignificant increase in blood SOD and GPx when 
compared with healthy normal group. On the other hand,
A. gehrtii leaves extract or cinnamoylamide to S. malayensis 
infected group showed a significant increase (P<0.05) in 
blood SOD but a highly significant increase (P<0.01) in blood 
GPx compared to the S. malayensis infected group.
  S. malayensis caused a significant increase (P<0.05) in 
serum MDA and plasma NO as compared with the normal 
Table 1
Effect of A. gehrtii and cinnamoylamide on liver function of S. malayensis infected mice.
Group AST 
(U/L)
ALT  
(U/L)
Total bilirubin
(mg/dL)
ALP
(U/L)
Total protein
(g/dL)
Albumin
(g/dL)
Globulin
(g/dL)
Albumin/
Globulin ratio
Control 123.1依3.8 62.5依2.5 0.56依0.08 210.5依6.8 7.64依0.72 3.76依0.45 3.88依0.25 0.97依0.05
S. malayensis  140.2依0.7*   82.0依2.0**  0.74依0.05*   241.2依7.1**  6.10依0.35*  2.81依0.17*  3.29依0.17*  0.85依0.03*
A. gehrtii+S. malayensis 126.4依4.2 60.1依2.9a  0.58依0.04a  215.1依6.6b  8.16依0.93a  3.96依0.48a  4.18依0.18b  0.95依0.04a
Cinnamoylamide+S. malayensis 128.3依3.9 65.0依2.9a  0.60依0.07a  223.0依4.9a  7.75依0.68a 3.86依0.65 3.89依0.25 0.90依0.07
Data presented as mean依SE. Number of animals=10 per group. *Significant change (P<0.05) compared to control healthy mice. **Highly 
significant change (P<0.01) compared to control healthy mice. aSignificant change (P<0.05) compared to S. malayensis group. bHighly significant 
change (P<0.01) compared to S. malayensis group.
Table 2
Effect of A. gehrtii and cinnamoylamide on lipid fractions of S. malayensis infected mice (mg/dL).
Group Cholesterol LDL Triglycerides HDL
Control  98.2依3.5  40.7依1.9 47.1依2.0 48.1依1.9
S. malayensis group 107.5依2.9*   46.1依1.9*  52.4依1.9* 50.9依2.0
A. gehrtii+S. malayensis group 101.4依4.1a 43.5依2.0 50.3依2.1 47.8依1.9
Cinnamoylamide+S. malayensis group  99.5依3.9  41.8依1.7a  48.2依1.7a 47.6依1.7
Data presented as mean依SE. Number of animals=10 per group. *Significant change (P<0.05) compared to control healthy mice. aSignificant 
change (P<0.05) compared to S. malayensis group.   
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healthy mice. A significant decrease (P<0.05) was observed 
in serum MDA and plasma NO in either group pretreated 
with A. gehrtii leaves extract or cinnamoylamide before
S. malayensis infection as compared with those infected with 
S. malayensis (Table 3).
3.5. Anti-apoptotic activity
  F i g u r e  1  s h o w s  t h e  p h o t o m i c r o g r a p h s  o f 
immunohistochemically stained liver tissue sections 
revealing that saline administration induced normal amount 
of expressed p53 (Figure 1A). On the other hand, the amount 
of p53 was potentially decreased in S. malayensis infected 
mice (Figure 1B) as compared to control healthy mice. The 
pretreatment of S. malayensis infected mice with A. gehrtii 
leaves extract or cinnamoylamide increased the amount of 
expressed p53 (Figure 1C & 1D) as compared to S. malayensis 
infected mice. 
  F i g u r e  2  e x h i b i t s  t h e  p h o t o m i c r o g r a p h s  o f 
immunohistochemically stained liver tissue sections 
revealing that normal mice showed normal amount of 
expressed bcl-2 (Figure 2A). On the other side, the amount 
of bcl-2 was potentially increased in S. malayensis 
infected mice (Figure 2B). The treatment of S. malayensis 
infected mice with either dose of A. gehrtii leaves extract 
or cinnamoylamide potentially decreased the elevated 
amount of expressed bcl-2 (Figure 2C & 2D) as compared to
S. malayensis infected mice. 
3.6. Histology study
  Figure 3 reveals the histopathology results in S. malayensis 
infected mice as well as A. gehrtii leaves extract or 
cinnamoylamide potentially pretreated groups. The structure 
a b c d
Figure 2. bcl-2 expression in control, S. malayensis-infected, cinnamoylamide and A. gehrtii extract pretreated mice.
(a) Immunohistochemically-stained kidney tissue sections showing bcl-2 expression in control healthy group which almost shows normal amount 
of expressed bcl-2. (b) S. malayensis strongly induced bcl-2 expression in liver sections. (c) There is partial inhibition of bcl-2 expression 
as evidenced by weak immune-staining in the mice liver treated with cinnamoylamide. (d) A. gehrtii leaves extract treatment showed lesser 
expression which implies that bcl-2 has been inhibited.
Figure 1.  p53 expression in control, S. malayensis-infected, cinnamoylamide and A. gehrtii extract pretreated mice.
(a) Immunohistochemically-stained liver tissue sections showing apoptotic marker, p53 expression in control mice. There is almost negligible 
expression of p53 in the liver sections of control group. (b) The tissue sections showing the effect of S. malayensis on apoptotic marker p53 
expression. S. malayensis decreased strongly p53 expression in liver sections. (c) There was partial expression of p53 as evidenced by weak 
immuno-staining in the mice liver treated with cinnamoylamide. (d) The expression of p53 was increased markedly on administration of A. 
gehrtii leaves extract which was well evident by the positive staining.
 
Table 3
Effect of A. gehrtii and cinnamoylamide on antioxidant idexes of S. malayensis infected mice.
Group SOD (U/mL) GPx (U/L) MDA (毺mol/L) NO (毺mol/L)
Control 260.0依8.4 6 250依83 3.51依0.26 35.8依1.8
S. malayensis group  236.9依7.9*  5 985依99*   5.76依0.54**   50.1依2.3**
A. gehrtii+S. malayensis group  258.7依8.6a  6 240依87a  3.56依0.38b  37.0依2.0b 
Cinnamoylamide+S. malayensis group  265.1依7.9a    6 435依100b  3.71依0.42b  40.5依1.9a
Data presented as mean依SE. Number of animals=10 per group. *Significant change (P<0.05) compared to control healthy mice. **Highly 
significant change (P<0.01) compared to control healthy mice. aSignificant change (P<0.05) compared to S. malayensis group. bHighly significant 
change (P<0.01) compared to S. malayensis group.
a b c d
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of the control liver showed normal hepatocytes, vascular 
sinusoids, and centrolobular vein (Figure 3A). S. malayensis 
infection caused liver granuloma with ova embedded in 
dense fibrous tissue. The thin-walled, non-striated helminth 
ova are not operculated and contain nonvital miracidial cells 
(Figure 3B). Examination of liver sections of rats pretreated 
with A. gehrtii leaves extract or cinnamoylamide prior to 
S. malayensis infection showed preserved hepatic lobular 
architecture. The hepatocytes were within normal limit and 
preserved its plate pattern. Liver almost returned to the 
normal pattern (Figure 3C & 3D).
 
4. Discussion
  In Malaysia, S. malayensis, in addition to Schnistosoma 
spindale, Schnistosoma nasale, Schnistosoma incognitum, 
Trichobilhazia brevis, and Pseudobilharziella lonchurae, is 
known to occur in wildlife[29]. The Robertsiella snails are 
the intermediate host of S. malayensis and have been found 
almost exclusively in small rivers[30]. Several attempts to 
recover eggs from feces from the Orang Asli population in 
peninsular Malaysia[31] were unsuccessful, however, which 
was attributed to the zoonotic nature of S. malayensis and 
thus missing adaptation to the human host. The rodent 
(jungle rat) feces could have contaminated the water with the 
eggs of S. malayensis.
  The mechanism of A. gehrtii protection in S. malayensis 
infection was dependant on the antioxidant activity of the 
plant amide to reduce the oxidative stress produced by
S.  malayensis  infect ion,  where amides at  lower 
concentrations have the ability to reduce schistosome 
pairing and motility. This effect was due to the functional 
group of the amine compounds which influenced the 
schistosomicidal activity[32].
  The aim of the present study was to evaluate the protective 
role of of A. gehrtii leaves extract in liver toxicity and 
apoptosis occurred in S. malayensis infection in male albino 
mice.
  The clinical and diagnostic values associated with the 
changes in blood enzyme concentrations such as AST, ALT, 
ALP, and serum bilirubin have long been recognized[33,34]. 
Increased levels of these diagnostic markers of hepatic 
function in S. malayensis infection in male mice are 
implicative of the degree of hepatocellular dysfunction 
caused by S. malayensis infection. Comparatively lower 
levels of these parameters in the pretreatment with A. gehrtii 
leaves extract or cinnamoylamide groups to S. malayensis 
mice show the ability of the phyto-constituents to protect 
the liver against harmful effects of S. malayensis.
  Albumin is the most abundant circulatory protein and 
its synthesis is a typical function of normal liver cells. 
Low levels of albumin have been reported in the serum 
of patients and animals with hepatocellular cancer[35]. 
The fall in the serum albumin levels could probably 
contribute to the low total protein levels observed in
S. malayensis infected mice. Considerably higher albumin 
and total protein levels were seen in A. gehrtii leaves 
extract or cinnamoylamide treated groups as compared to S. 
malayensis group, indicating that one of the mechanisms by 
which the phytoconstituents exhibit their protective effects 
during cancer is by enhancing the levels of albumin and 
thereby total protein levels. Thus, based on our preliminary 
biochemical findings, we suggest possible preventive effects 
of A. gehrtii leaves extract and 0S. malayensis infection.
  S. malayensis increased significantly serum cholesterol, 
LDL, and triglycerides, while A. gehrtii leaves extract or 
cinnamoylamide pretreatment directed serum cholesterol, 
LDL, and triglycerides to the normal levels. This effect may 
be related to amides-containing plant which protects LDLs 
from oxidation. Lipids targeted for cellular metabolism 
are mobilized from the intestine as: (栺) triglycerides-
rich chylomicrons; (栻) triglycerides-rich very-low-
density lipoproteins, which are subsequently converted to 
cholesterol-rich LDL; and (栿) as cholesterol-phospholipid-
rich HDL, which removes cholesterol from peripheral 
cells and transports it to the liver[36]. Such findings are in 
agreement with that of Rashed et al[37], Xu et al[38], and Park 
a b c d
Figure 3. Liver histology in control, S. malayensis-infected, cinnamoylamide and A. gehrtii extract pretreated mice.
(a) Shows the control group with preserved hepatic architecture (H&E, ×200). (b) Shows S. malayensis liver granuloma with ova embedded 
in dense fibrous tissue (arrows). The thin-walled, non-striated helminth ova are not operculated and contain nonvital miracidial cells was 
found (H&E, ×200). (c) Shows pretreatment of cinnamoylamide to S. malayensis infected mice with preserved hepatic lobular architecture. 
The hepatocytes are within normal limit and preserve its plate pattern. Liver almost returns to the normal pattern (H&E, ×200). (d) Shows 
pretreatment of A. gehrtii leaves extract to S. malayensis infected mice with large reserved hepatic lobular architecture and the liver almost 
returns to the normal pattern (H&E, ×200).  
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et al[39] who found that the amides potently inhibited rabbit 
liver acyl-CoA: cholesterol O-acyltransferase, and also 
decreased significantly the plasma cholesterol (42%-68%) in 
an acute cholesterol-fed rat model.
  S. malayensis decreased significantly blood GPx and SOD 
activities but increased serum MDA and plasma NO. On 
the contrary, A. gehrtii leaves extract or cinnamoylamide 
pretreatment increased blood GPx and SOD activities but 
decreased serum MDA and plasma NO. This observation 
could be related to the antioxidant effect of amides-
containing plant. Such findings are accepted with that 
of Marinova et al[40] and Storozhok et al[41] who found 
thatcinnamoyl- and hydroxycinnamoyl amides of biogenic 
amines exhibited an excellent antioxidant activity, higher 
than or comparable with that of caffeic acid.
  In the current study, anti-apoptotic activity of A. gehrtii 
leaves extract or cinnamoylamide was also recorded. P53 and 
bcl-2 are closely related to the majority of human toxicity 
and cancer[42]. Apoptotic marker p53 is a critical regulator 
of apoptosis in many cells. It stimulates a wide network 
of signals that act through either extrinsic or intrinsic 
pathways of apoptosis[43] by activating the transcription of 
downstream genes such as p21 and Bax to induce apoptotic 
process which inhibit the growth of cells with damaged 
DNA. On the other hand, bcl-2 has been reported to function 
primarily by blocking the apoptosis pathway[44]. Bcl-2 gene 
product is a negative regulator of apoptosis, which forms a 
heterodimer complex with Bax and neutralizes the effect of 
pro-apoptosis[45]. Our results indicated that S. malayensis 
decreased p53 expression but increased bcl-2 expression. 
On the other side, the treatment with A. gehrtii leaves 
extract or cinnamoylamide to S. malayensis infected mice 
increased p53 expression but decreased bcl-2 expression. 
These results are in agreement with that of Mulware[46] 
who reported that parasite or environmental toxicant cause 
induction of oxidative-induced DNA damage by ROS 
may lead to isolated base lesions or single-strand breaks, 
complex lesions like double-strand breaks, and some 
oxidative generated clustered DNA lesions which are linked 
to cell apoptosis and mutagenesis. On the other side, the
A. gehrtii leaves extract or cinnamoylamide has anti-
apoptotic activity, where the plant leaves extract, an 
inhibitor of p53, abrogated glucolipotoxicity-induced ROS 
generation and p53 expression[47]. 
  Histopathological studies of liver tissues of normal,
S. malayensis infected group and A. gehrtii leaves extract or 
cinnamoylamide + S. malayensis-infected groups indicate 
that either plant extract or alkamide has cytoprotective 
properties.
  Data from the present study highlights S. malayensis fatal 
effects on oxidative stress and apoptosis in the liver of male 
albino mice. Pretreatment of A. gehrtii showed significant 
reduction in liver oxidative stress and apoptosis in
S. malayensis evidenced in histological examinations, and 
this effect was associated with cinnamoylamide ingredient 
of the plant leaves. However, further clinical studies are 
warranted to establish its effectiveness and it will be 
interesting to see whether A. gehrtii reverses existing S. 
malayensis liver toxicity and apoptosis, like in real case 
scenarios.
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